0 Tuberculosis: ‘Suicide’ toxin–antitoxin system identified as a drug target
Researchers have investigated a toxin–antitoxin system in tuberculosis as a therapeutic target, providing the first high-resolution details.
Browsing: Basic > Pathology & Pathogenesis
0 A peek behind the paper – Dr Shabana on quorum quenching
Take a look behind the scenes of a recent Future Microbiology review as we ask the authors about quorum quenching and using nanoparticles as antibiotics.
0 Could a westernized diet impact sepsis severity and mortality rates?
Findings from a study at Portland State University suggest the severity of sepsis development and the subsequent outcome can be worsened through eating a ‘Western’ diet, high in both sugar and fat.
0 Can sleep improve our T cell responses?
A new study has suggested that sleep causes a dip in Gαs-coupled receptor agonists, in turn improving T cell integrin activation – a process T cells use to target viral cells.
0 Could gene therapy be an effective treatment for chlamydia?
New research has developed a nanoparticle formulation that can knock down a key chlamydia binding protein and simultaneously induce autophagy – showing promise against this infection.
0 Novel genetic tool allows for accurate measures of latent HIV reservoirs within cells
Researchers from the Howard Hughes Medical Institute have developed a novel genetic tool for detecting fast and accurate measures of latent HIV.
0 Do basophils hold a key role in fighting bacterial infection?
New research has provided evidence that basophils might play an important role in the immune response to bacterial infections, preventing the development of sepsis.
0 Panellist Picks – our panel’s favorite papers of 2018
To round up 2018, we asked our Expert panel to choose their top papers from across the year. Here, you can discover the articles they selected and read about and the reasons why!
0 Epstein-Barr virus and schizophrenia linked by abnormal immune response
Individuals with schizophrenia also have higher level of antibodies against the Epstein-Barr virus, according to new research.
0 Can Candida albicans cross the blood–brain barrier?
Researchers have discovered Candida albicans can cross the blood–brain barrier, triggering an immune response that results in the formation of granuloma-type structures and memory impairments.
